These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 19915523)

  • 1. Micropapillary ductal carcinoma in situ of the breast: an inter-institutional study.
    Castellano I; Marchiò C; Tomatis M; Ponti A; Casella D; Bianchi S; Vezzosi V; Arisio R; Pietribiasi F; Frigerio A; Mano MP; Ricardi U; Allia E; Accortanzo V; Durando A; Bussolati G; Tot T; Sapino A
    Mod Pathol; 2010 Feb; 23(2):260-9. PubMed ID: 19915523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship of a new histological categorization of ductal carcinoma in situ of the breast with size and the immunohistochemical expression of p53, c-erb B2, bcl-2, and ki-67.
    Mack L; Kerkvliet N; Doig G; O'Malley FP
    Hum Pathol; 1997 Aug; 28(8):974-9. PubMed ID: 9269835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of pathological and biological features of symptomatic and mammographically detected ductal carcinoma in situ of the breast.
    Walker RA; Dearing SJ; Brown LA
    Hum Pathol; 1999 Aug; 30(8):943-8. PubMed ID: 10452507
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ductal carcinoma in situ of the breast. Histologic categorization and its relationship to ploidy and immunohistochemical expression of hormone receptors, p53, and c-erbB-2 protein.
    Leal CB; Schmitt FC; Bento MJ; Maia NC; Lopes CS
    Cancer; 1995 Apr; 75(8):2123-31. PubMed ID: 7697603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of Her2/neu, estrogen and progesterone receptors in invasive micropapillary carcinoma of the breast.
    Kuroda H; Sakamoto G; Ohnisi K; Itoyama S
    Breast Cancer; 2004; 11(3):301-6. PubMed ID: 15550850
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predictors of recurrence in breast cancer subtypes with negative lymph node in a Chinese population.
    Liu X; Guan Y; Zhang W; Liu S; Liu J; Wang L; Niu Y
    Int J Clin Exp Pathol; 2014; 7(6):3202-12. PubMed ID: 25031741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinic-Pathological Features of Breast Ductal Carcinoma
    Zheng J; Zhou T; Li F; Shi J; Zhang L
    Cancer Invest; 2020 Feb; 38(2):113-121. PubMed ID: 31939679
    [No Abstract]   [Full Text] [Related]  

  • 8. [Breast ductal carcinoma in situ with microinvasion: pathological review and clinical implications].
    Modesto A; Gandy C; Mery E; Filleron T; Massabeau C; Izar F; Charitansky H; Roché H; de Lafontan B
    Cancer Radiother; 2014 Mar; 18(2):107-10. PubMed ID: 24637020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The clinical relevance of micropapillary carcinoma of the breast: a case-control study.
    Vingiani A; Maisonneuve P; Dell'orto P; Farante G; Rotmensz N; Lissidini G; Del Castillo A; Renne G; Luini A; Colleoni M; Viale G; Pruneri G
    Histopathology; 2013 Aug; 63(2):217-24. PubMed ID: 23763700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Invasive micropapillary carcinoma of the breast: high incidence of lymph node metastasis with extranodal extension and its immunohistochemical profile compared with invasive ductal carcinoma.
    Zekioglu O; Erhan Y; Ciris M; Bayramoglu H; Ozdemir N
    Histopathology; 2004 Jan; 44(1):18-23. PubMed ID: 14717664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Invasive micropapillary carcinoma of the breast: a clinicopathologic study of 103 cases of an unusual and highly aggressive variant of breast carcinoma.
    Gokce H; Durak MG; Akin MM; Canda T; Balci P; Ellidokuz H; Demirkan B; Gorken IB; Sevinc AI; Kocdor MA; Saydam S; Harmancioglu O
    Breast J; 2013; 19(4):374-81. PubMed ID: 23714006
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinicopathologic study of centrally necrotizing carcinoma of breast].
    Yu L; Yang WT; Cai X; Lu HF; Fan YZ; Shi DR
    Zhonghua Bing Li Xue Za Zhi; 2009 Oct; 38(10):657-62. PubMed ID: 20078968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intense basolateral membrane staining indicates HER2 positivity in invasive micropapillary breast carcinoma.
    Zhou S; Yang F; Bai Q; Li A; Li M; Zhong S; Lv H; Shui R; Tu X; Bi R; Xu X; Cheng Y; Yu B; Tang S; Sun X; Zhou X; Yang W
    Mod Pathol; 2020 Jul; 33(7):1275-1286. PubMed ID: 31974492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ductal carcinoma in situ treated with lumpectomy and irradiation: histopathological analysis of 49 specimens with emphasis on risk factors and long term results.
    Sneige N; McNeese MD; Atkinson EN; Ames FC; Kemp B; Sahin A; Ayala AG
    Hum Pathol; 1995 Jun; 26(6):642-9. PubMed ID: 7774895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of astrocyte elevated gene-1, basic-fibroblast growth factor, beta-catenin, Ki-67, tumor necrosis factor-alfa with prognostic parameters in ductal carcinomas and ductal intraepithelial neoplasms.
    Erdem H; Gundogdu B; Ankarali H; Yasar M; Sener E; Oktay M; Bahadir A; Uzunlar AK; Gursan N; Ozaydin I; Sahiner C
    Niger J Clin Pract; 2015; 18(5):638-43. PubMed ID: 26096243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinicopathologic features of micropapillary variant of pure mucinous carcinoma of breast].
    Lin HY; Gao LX; Jin ML; Ding HY
    Zhonghua Bing Li Xue Za Zhi; 2012 Sep; 41(9):613-7. PubMed ID: 23157830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microinvasive ductal carcinoma (T1mic) of the breast. The clinicopathological profile and immunohistochemical features of 28 cases.
    Yang M; Moriya T; Oguma M; De La Cruz C; Endoh M; Ishida T; Hirakawa H; Orita Y; Ohuchi N; Sasano H
    Pathol Int; 2003 Jul; 53(7):422-8. PubMed ID: 12828606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Declining recurrence among ductal carcinoma in situ patients treated with breast-conserving surgery in the community setting.
    Habel LA; Achacoso NS; Haque R; Nekhlyudov L; Fletcher SW; Schnitt SJ; Collins LC; Geiger AM; Puligandla B; Acton L; Quesenberry CP
    Breast Cancer Res; 2009; 11(6):R85. PubMed ID: 19922614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein expression of c-erbB-2 and p53 in normal ducts, ductal carcinoma in situ and invasive carcinoma of the same breast.
    Menezes MV; Cestari AL; Almeida O; Alvarenga M; Pinto GA; Gurgel MS; Souza GA; Zeferino LC
    Sao Paulo Med J; 2006 May; 124(3):121-4. PubMed ID: 17119686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.
    Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Mizutoh A; Moriya T; Sonoo H
    Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.